Bevacizumab-associated osteonecrosis of the jaw
- PMID: 18977851
- PMCID: PMC2733125
- DOI: 10.1093/annonc/mdn653
Bevacizumab-associated osteonecrosis of the jaw
Figures
References
-
- Woo S-B, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaw. Ann Intern Med. 2006;144:753–761. - PubMed
-
- Vincenzi B, Santini D, Rocci L, Tonini G. Bisphosphonates: new antiangiogenic molecules in cancer treatment? Ann Oncol. 2003;14:806–807. - PubMed
-
- Kim KJ, Li B, Houck K, et al. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 1992;7:53–64. - PubMed
-
- Estilo CL, Fornier M, Farooki A, et al. Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol. 2008;26:4037–4038. - PubMed
-
- Palaia I, Angioli R, Bellati F, et al. Distal phalange necrosis: a severe manifestation of palmar plantar erythrodysesthesia. Am J Obstet Gynecol. 2006;195:e1–e2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
